Boston Scientific Announces Agreement To Acquire Augmenix, Inc.

Author's Avatar
Sep 07, 2018
Article's Main Image

Acquisition expands portfolio of men's health in-office procedures with adjunctive therapy for prostate cancer patients

PR Newswire